Cart
sales@molnova.com
BYK204165
CAS No. 1104546-89-5
BYK204165( RT-017290 )
Catalog No. M21123 CAS No. 1104546-89-5
BYK204165 is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 170 | In Stock |
|
| 50MG | 245 | In Stock |
|
| 100MG | 361 | In Stock |
|
| 200MG | 528 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBYK204165
-
NoteResearch use only, not for human use.
-
Brief DescriptionBYK204165 is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
-
DescriptionBYK204165 is a potent PARP inhibitor (PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
-
In Vitro——
-
In Vivo——
-
SynonymsRT-017290
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1104546-89-5
-
Formula Weight252
-
Molecular FormulaC15H12N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (495.50 mM; Need ultrasonic)
-
SMILESCn1cccc1C=C1C(=O)NC(=O)c2ccccc21
-
Chemical Name(4Z)-4-[(1-methylpyrrol-2-yl)methylidene]isoquinoline-13-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eltze T Boer R Wagner T et al. Imidazoquinolinone imidazopyridine and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.[J]. molecular pharmacology 2008 74(6):1587-1598.
molnova catalog
related products
-
Desmethyl-VS-5584
Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
-
KSQ-4279
KSQ-4279 (USP1-IN-1) is an inhibitor of USP1 and PARP, exhibiting anticancer activity. It is utilized in the study of non-small cell lung cancer, osteosarcoma, ovarian, breast, glioblastoma, bladder, uterine, and pancreatic cancers.
-
RBN-3143
RBN-3143 is a potent inhibitor of NAD+-competitive catalytic PARP14 (IC50= 4 nM), which inhibits ADP-ribosylation mediated by PARP14 and stabilizes PARP14 in cell lines, demonstrating research potential for lung inflammation.
